Cargando…
Functional Investigation of the Tumoural Heterogeneity of Intrahepatic Cholangiocarcinoma by In Vivo PET-CT Navigation: A Proof-of-Concept Study
Intra-tumoural heterogeneity (IH) is a major determinant of resistance to therapy and outcomes but remains poorly translated into clinical practice. Intrahepatic cholangiocarcinoma (ICC) often presents as large heterogeneous masses at imaging. The present study proposed an innovative in vivo techniq...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501620/ https://www.ncbi.nlm.nih.gov/pubmed/36143097 http://dx.doi.org/10.3390/jcm11185451 |
_version_ | 1784795519791398912 |
---|---|
author | Viganò, Luca Lopci, Egesta Di Tommaso, Luca Destro, Annarita Aghemo, Alessio Rimassa, Lorenza Solbiati, Luigi Chiti, Arturo Torzilli, Guido Fiz, Francesco |
author_facet | Viganò, Luca Lopci, Egesta Di Tommaso, Luca Destro, Annarita Aghemo, Alessio Rimassa, Lorenza Solbiati, Luigi Chiti, Arturo Torzilli, Guido Fiz, Francesco |
author_sort | Viganò, Luca |
collection | PubMed |
description | Intra-tumoural heterogeneity (IH) is a major determinant of resistance to therapy and outcomes but remains poorly translated into clinical practice. Intrahepatic cholangiocarcinoma (ICC) often presents as large heterogeneous masses at imaging. The present study proposed an innovative in vivo technique to functionally assess the IH of ICC. Preoperative 18F-FDG PET-CT and intraoperative ultrasonography were merged to perform the intraoperative navigation of functional tumour heterogeneity. The tumour areas with the highest and the lowest metabolism (SUV) at PET-CT were selected, identified during surgery, and sampled. Three consecutive patients underwent the procedure. The areas with the highest uptake at PET-CT had higher proliferation index (KI67) values and higher immune infiltration compared to areas with the lowest uptake. One of the patients showed a heterogeneous presence of FGFR2 translocation within the samples. Tumour heterogeneity at PET-CT may drive biopsy to sample the most informative ICC areas. Even more relevant, these preliminary data show the possibility of achieving a non-invasive evaluation of IH in ICC, paving the way for an imaging-based precision-medicine approach. |
format | Online Article Text |
id | pubmed-9501620 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95016202022-09-24 Functional Investigation of the Tumoural Heterogeneity of Intrahepatic Cholangiocarcinoma by In Vivo PET-CT Navigation: A Proof-of-Concept Study Viganò, Luca Lopci, Egesta Di Tommaso, Luca Destro, Annarita Aghemo, Alessio Rimassa, Lorenza Solbiati, Luigi Chiti, Arturo Torzilli, Guido Fiz, Francesco J Clin Med Article Intra-tumoural heterogeneity (IH) is a major determinant of resistance to therapy and outcomes but remains poorly translated into clinical practice. Intrahepatic cholangiocarcinoma (ICC) often presents as large heterogeneous masses at imaging. The present study proposed an innovative in vivo technique to functionally assess the IH of ICC. Preoperative 18F-FDG PET-CT and intraoperative ultrasonography were merged to perform the intraoperative navigation of functional tumour heterogeneity. The tumour areas with the highest and the lowest metabolism (SUV) at PET-CT were selected, identified during surgery, and sampled. Three consecutive patients underwent the procedure. The areas with the highest uptake at PET-CT had higher proliferation index (KI67) values and higher immune infiltration compared to areas with the lowest uptake. One of the patients showed a heterogeneous presence of FGFR2 translocation within the samples. Tumour heterogeneity at PET-CT may drive biopsy to sample the most informative ICC areas. Even more relevant, these preliminary data show the possibility of achieving a non-invasive evaluation of IH in ICC, paving the way for an imaging-based precision-medicine approach. MDPI 2022-09-16 /pmc/articles/PMC9501620/ /pubmed/36143097 http://dx.doi.org/10.3390/jcm11185451 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Viganò, Luca Lopci, Egesta Di Tommaso, Luca Destro, Annarita Aghemo, Alessio Rimassa, Lorenza Solbiati, Luigi Chiti, Arturo Torzilli, Guido Fiz, Francesco Functional Investigation of the Tumoural Heterogeneity of Intrahepatic Cholangiocarcinoma by In Vivo PET-CT Navigation: A Proof-of-Concept Study |
title | Functional Investigation of the Tumoural Heterogeneity of Intrahepatic Cholangiocarcinoma by In Vivo PET-CT Navigation: A Proof-of-Concept Study |
title_full | Functional Investigation of the Tumoural Heterogeneity of Intrahepatic Cholangiocarcinoma by In Vivo PET-CT Navigation: A Proof-of-Concept Study |
title_fullStr | Functional Investigation of the Tumoural Heterogeneity of Intrahepatic Cholangiocarcinoma by In Vivo PET-CT Navigation: A Proof-of-Concept Study |
title_full_unstemmed | Functional Investigation of the Tumoural Heterogeneity of Intrahepatic Cholangiocarcinoma by In Vivo PET-CT Navigation: A Proof-of-Concept Study |
title_short | Functional Investigation of the Tumoural Heterogeneity of Intrahepatic Cholangiocarcinoma by In Vivo PET-CT Navigation: A Proof-of-Concept Study |
title_sort | functional investigation of the tumoural heterogeneity of intrahepatic cholangiocarcinoma by in vivo pet-ct navigation: a proof-of-concept study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501620/ https://www.ncbi.nlm.nih.gov/pubmed/36143097 http://dx.doi.org/10.3390/jcm11185451 |
work_keys_str_mv | AT viganoluca functionalinvestigationofthetumouralheterogeneityofintrahepaticcholangiocarcinomabyinvivopetctnavigationaproofofconceptstudy AT lopciegesta functionalinvestigationofthetumouralheterogeneityofintrahepaticcholangiocarcinomabyinvivopetctnavigationaproofofconceptstudy AT ditommasoluca functionalinvestigationofthetumouralheterogeneityofintrahepaticcholangiocarcinomabyinvivopetctnavigationaproofofconceptstudy AT destroannarita functionalinvestigationofthetumouralheterogeneityofintrahepaticcholangiocarcinomabyinvivopetctnavigationaproofofconceptstudy AT aghemoalessio functionalinvestigationofthetumouralheterogeneityofintrahepaticcholangiocarcinomabyinvivopetctnavigationaproofofconceptstudy AT rimassalorenza functionalinvestigationofthetumouralheterogeneityofintrahepaticcholangiocarcinomabyinvivopetctnavigationaproofofconceptstudy AT solbiatiluigi functionalinvestigationofthetumouralheterogeneityofintrahepaticcholangiocarcinomabyinvivopetctnavigationaproofofconceptstudy AT chitiarturo functionalinvestigationofthetumouralheterogeneityofintrahepaticcholangiocarcinomabyinvivopetctnavigationaproofofconceptstudy AT torzilliguido functionalinvestigationofthetumouralheterogeneityofintrahepaticcholangiocarcinomabyinvivopetctnavigationaproofofconceptstudy AT fizfrancesco functionalinvestigationofthetumouralheterogeneityofintrahepaticcholangiocarcinomabyinvivopetctnavigationaproofofconceptstudy |